Literature DB >> 8675618

Gene therapy for cystic fibrosis: challenges and future directions.

J M Wilson1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8675618      PMCID： PMC185958          DOI： 10.1172/JCI118318

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  80 in total

1.  Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis.

Authors:  R G Crystal; N G McElvaney; M A Rosenfeld; C S Chu; A Mastrangeli; J G Hay; S L Brody; H A Jaffe; N T Eissa; C Danel
Journal:  Nat Genet       Date:  1994-09       Impact factor: 38.330

2.  Gene therapy of cystic fibrosis lung disease using E1 deleted adenoviruses: a phase I trial.

Authors:  J M Wilson; J F Engelhardt; M Grossman; R H Simon; Y Yang
Journal:  Hum Gene Ther       Date:  1994-04       Impact factor: 5.695

3.  In vivo evaluation of the safety of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA to the lung.

Authors:  S Yei; N Mittereder; S Wert; J A Whitsett; R W Wilmott; B C Trapnell
Journal:  Hum Gene Ther       Date:  1994-06       Impact factor: 5.695

4.  [Ca2+]i inhibition of Ca2+ release-activated Ca2+ influx underlies agonist- and thapsigargin-induced [Ca2+]i oscillations in salivary acinar cells.

Authors:  J K Foskett; D C Wong
Journal:  J Biol Chem       Date:  1994-12-16       Impact factor: 5.157

5.  Gene therapy for cystic fibrosis using E1-deleted adenovirus: a phase I trial in the nasal cavity. The University of North Carolina at Chapel Hill.

Authors:  R C Boucher; M R Knowles; L G Johnson; J C Olsen; R Pickles; J M Wilson; J Engelhardt; Y Yang; M Grossman
Journal:  Hum Gene Ther       Date:  1994-05       Impact factor: 5.695

6.  Correction of cAMP-stimulated fluid secretion in cystic fibrosis airway epithelia: efficiency of adenovirus-mediated gene transfer in vitro.

Authors:  J Zabner; L A Couture; A E Smith; M J Welsh
Journal:  Hum Gene Ther       Date:  1994-05       Impact factor: 5.695

7.  Inefficient gene transfer by adenovirus vector to cystic fibrosis airway epithelia of mice and humans.

Authors:  B R Grubb; R J Pickles; H Ye; J R Yankaskas; R N Vick; J F Engelhardt; J M Wilson; L G Johnson; R C Boucher
Journal:  Nature       Date:  1994-10-27       Impact factor: 49.962

8.  Acute responses of non-human primates to airway delivery of an adenovirus vector containing the human cystic fibrosis transmembrane conductance regulator cDNA.

Authors:  S L Brody; M Metzger; C Danel; M A Rosenfeld; R G Crystal
Journal:  Hum Gene Ther       Date:  1994-07       Impact factor: 5.695

Review 9.  The role of CD40 in the regulation of humoral and cell-mediated immunity.

Authors:  F H Durie; T M Foy; S R Masters; J D Laman; R J Noelle
Journal:  Immunol Today       Date:  1994-09

10.  Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis.

Authors:  Y Yang; F A Nunes; K Berencsi; E Gönczöl; J F Engelhardt; J M Wilson
Journal:  Nat Genet       Date:  1994-07       Impact factor: 38.330
View more
  15 in total

1.  Recombinant GABA(C) receptors expressed in rat hippocampal neurons after infection with an adenovirus containing the human rho1 subunit.

Authors:  N Filippova; A Sedelnikova; W J Tyler; T L Whitworth; H Fortinberry; D S Weiss
Journal:  J Physiol       Date:  2001-08-15       Impact factor: 5.182

2.  Chloride secretion in the trachea of null cystic fibrosis mice: the effects of transfection with pTrial10-CFTR2.

Authors:  L J MacVinish; D R Gill; S C Hyde; K A Mofford; M J Evans; C F Higgins; W H Colledge; L Huang; F Sorgi; R Ratcliff; A W Cuthbert
Journal:  J Physiol       Date:  1997-03-15       Impact factor: 5.182

3.  Gene therapy, early promises, subsequent problems, and recent breakthroughs.

Authors:  Saeideh Razi Soofiyani; Behzad Baradaran; Farzaneh Lotfipour; Tohid Kazemi; Leila Mohammadnejad
Journal:  Adv Pharm Bull       Date:  2013-08-20

4.  Animal models of human disease for gene therapy.

Authors:  J M Wilson
Journal:  J Clin Invest       Date:  1996-03-01       Impact factor: 14.808

Review 5.  The innate immune system in cystic fibrosis lung disease.

Authors:  R Bals; D J Weiner; J M Wilson
Journal:  J Clin Invest       Date:  1999-02       Impact factor: 14.808

6.  Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers.

Authors:  K Jooss; Y Yang; K J Fisher; J M Wilson
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

7.  Application of a Fas ligand encoding a recombinant adenovirus vector for prolongation of transgene expression.

Authors:  H G Zhang; G Bilbao; T Zhou; J L Contreras; J Gómez-Navarro; M Feng; I Saito; J D Mountz; D T Curiel
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

8.  Differential sensitivity of normal and cystic fibrosis airway epithelial cells to epinephrine.

Authors:  K K Goncz; L Feeney; D C Gruenert
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

9.  Disrupted adenovirus-based vaccines against small addictive molecules circumvent anti-adenovirus immunity.

Authors:  Bishnu P De; Odelya E Pagovich; Martin J Hicks; Jonathan B Rosenberg; Amira Y Moreno; Kim D Janda; George F Koob; Stefan Worgall; Stephen M Kaminsky; Dolan Sondhi; Ronald G Crystal
Journal:  Hum Gene Ther       Date:  2012-12-21       Impact factor: 5.695

10.  Gene transfer by guanidinium-cholesterol cationic lipids into airway epithelial cells in vitro and in vivo.

Authors:  N Oudrhiri; J P Vigneron; M Peuchmaur; T Leclerc; J M Lehn; P Lehn
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-04       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.